Radiation Oncology Journal

Feasibility study of manual dose escalation method with normal tissue complication probability in radiation dose escalation for prostate cancer

Denis Yoo, Byung Jun Min, C. J. Rah, Eric Lee, Jeong Hoon Park, Dongho Shin, Eun Ho Kim

Journal of the Korean Physical Society.2023;[Epub] CrossRef

Study of the calculation of the oxygen enhancement ratio for a carbon ion beam with fraction and linear energy transfer using various survival models

Denis Yoo, Jeong-Yub Kim, Byung Jun Min, C. J. Rah, Eric Lee, Won Il Jang, Eun Ho Kim

Journal of the Korean Physical Society.2022; 80(6): 496. CrossRef

An investigation of oxygen enhancement ratio modeling for proton dose calculation

Denis Yoo, Chang Ju Rah, Erick Lee, Ji Hwan Kim, Jeong Hoon Park, Byung Jun Min

Journal of the Korean Physical Society.2022; 81(11): 1081. CrossRef

Kidney Graft Urothelial Carcinoma: Results From a Multicentric Retrospective National Study

Grégoire Leon, Nicolas Szabla, Romain Boissier, Marc Gigante, Kevin Caillet, Gregory Verhoest, Xavier Tillou

Prostate-specific antigen is a predictor of the efficacy of salvage radiation therapy in patients with recurrent prostate cancer after radical prostatectomy

Р. V. Bulychkin, S. I. Tkachev, V. B. Matveev, A. V. Nazarenko

Importance of the site of positive surgical margin in salvage external beam radiation therapy for biochemical recurrence of prostate cancer after radical prostatectomy

Tairo Kashihara, Satoshi Nakamura, Akihisa Wakita, Hiroyuki Okamoto, Koji Inaba, Rei Umezawa, Satoshi Shima, Keisuke Tsuchida, Kazuma Kobayashi, Kana Takahashi, Naoya Murakami, Yoshinori Ito, Hiroshi Igaki, Hiroyuki Fujimoto, Takashi Uno, Jun Itami

Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer

Amar U. Kishan, Rahul D. Tendulkar, Phuoc T. Tran, Christopher C. Parker, Paul L. Nguyen, Andrew J. Stephenson, Christian Carrie

European Urology Oncology.2018; 1(1): 3. CrossRef

Patterns of Postprostatectomy Adjuvant Radiotherapy Techniques for Nonmetastatic Prostate Cancer in a Large National Cohort

Andrew T. Wong, David Schwartz, Anna Lee, Joseph Safdieh, Virginia Osborn, David Schreiber

Clinical Genitourinary Cancer.2017; 15(1): 168. CrossRef

Phase 1/2 Dose-Escalation Study of the Use of Intensity Modulated Radiation Therapy to Treat the Prostate and Pelvic Nodes in Patients With Prostate Cancer

Miguel Reis Ferreira, Atia Khan, Karen Thomas, Lesley Truelove, Helen McNair, Annie Gao, Chris C. Parker, Robert Huddart, Margaret Bidmead, Ros Eeles, Vincent Khoo, Nicholas J. van As, Vibeke N. Hansen, David P. Dearnaley

International Journal of Radiation Oncology*Biology*Physics.2017; 99(5): 1234. CrossRef

Rectal dose to prostate cancer patients treated with proton therapy with or without rectal spacer

Heeteak Chung, Jerimy Polf, Shahed Badiyan, Matthew Biagioli, Daniel Fernandez, Kujtim Latifi, Richard Wilder, Minesh Mehta, Michael Chuong

Journal of Applied Clinical Medical Physics.2017; 18(1): 32. CrossRef

Radiotherapy after prostatectomy: prognosis, timing and outcomes

British Journal of Nursing.2016; 25(18): S4. CrossRef

Radiosensitization by the investigational NEDD8-activating enzyme inhibitor MLN4924 (pevonedistat) in hormone-resistant prostate cancer cells

Xiaofang Wang, Wenjuan Zhang, Zi Yan, Yupei Liang, Lihui Li, Xiaoli Yu, Yan Feng, Shen Fu, Yanmei Zhang, Hu Zhao, Jinha Yu, Lak Shin Jeong, Xiaomao Guo, Lijun Jia

Clinical and biochemical outcomes of men undergoing radical prostatectomy or radiation therapy for localized prostate cancer

David Schreiber, Justin Rineer, Jeffrey P. Weiss, Joseph Safdieh, Joseph Weiner, Marvin Rotman, David Schwartz

Radiation Oncology Journal.2015; 33(1): 21. CrossRef